Dr. Benjamin Haibe-Kains is the Executive AI Scientific Director at the University Health Network, a Senior Scientist at the Princess Margaret Cancer Centre, University Health Network, and a Professor in the Department of Medical Biophysics at the University of Toronto (Canada). He earned his PhD in Bioinformatics from the Université Libre de Bruxelles (Belgium) and pursued postdoctoral training at the Dana-Farber Cancer Institute and the Harvard School of Public Health (USA) as a Fulbright Scholar.

Dr. Haibe-Kains holds the Canada Research Chair in Computational Pharmacogenomics and serves as Scientific Director of the Cancer Digital Intelligence Program at Princess Margaret and the AI Hub at the University Health Network. He is also Head of Data Science at the Structural Genomics Consortium. His research harnesses artificial intelligence (AI) and machine learning (ML) to integrate large-scale chemical, radiological, and (pharmaco)genomic datasets. By developing predictive models for drug development, cancer progression and treatment response, his team aims to accelerate innovation in precision medicine and ultimately improve outcomes for patients.